Detalles de la búsqueda
1.
Glucokinase activation leads to an unsustained hypoglycaemic effect with hepatic triglyceride accumulation in db/db mice.
Diabetes Obes Metab
; 24(3): 391-401, 2022 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-34704329
2.
Glucokinase activation or inactivation: Which will lead to the treatment of type 2 diabetes?
Diabetes Obes Metab
; 23(10): 2199-2206, 2021 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-34105236
3.
Severe infection including disseminated herpes zoster triggered by subclinical Cushing's disease: a case report.
BMC Endocr Disord
; 21(1): 84, 2021 Apr 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-33906651
4.
Favourable effect of the sodium-glucose co-transporter-2 inhibitor canagliflozin plus the dipeptidyl peptidase-4 inhibitor teneligliptin in combination on glycaemic fluctuation: An open-label, prospective, randomized, parallel-group comparison trial (the CALMER study).
Diabetes Obes Metab
; 22(3): 458-462, 2020 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-31486230
5.
Effect of switching from pioglitazone to the sodium glucose co-transporter-2 inhibitor dapagliflozin on body weight and metabolism-related factors in patients with type 2 diabetes mellitus: An open-label, prospective, randomized, parallel-group comparison trial.
Diabetes Obes Metab
; 21(3): 710-714, 2019 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-30311367
6.
Satisfaction and efficacy of switching from daily dipeptidyl peptidase-4 inhibitors to weekly trelagliptin in patients with type 2 diabetes-Randomized controlled study.
Endocr J
; 65(2): 141-150, 2018 Feb 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-29093280
7.
Switching from Conventional Fibrates to Pemafibrate Has Beneficial Effects on the Renal Function of Diabetic Subjects with Chronic Kidney Disease.
Diabetes Metab J
; 48(3): 473-481, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38419467
8.
Luseogliflozin preserves the pancreatic beta-cell mass and function in db/db mice by improving mitochondrial function.
Sci Rep
; 12(1): 9740, 2022 06 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-35697838
9.
The agreement between measured HbA1c and optimized target HbA1c based on the Dementia Assessment Sheet for Community-based Integrated Care System 8-items (DASC-8): A cross-sectional study of elderly patients with diabetes.
Geriatr Gerontol Int
; 22(8): 560-567, 2022 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-35773969
10.
Effects of pemafibrate on lipid metabolism in patients with type 2 diabetes and hypertriglyceridemia: A multi-center prospective observational study, the PARM-T2D study.
Diabetes Res Clin Pract
; 192: 110091, 2022 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-36174777
11.
Impact of endogenous insulin secretion on the improvement of glucose variability in Japanese patients with type 2 diabetes treated with canagliflozin plus teneligliptin.
J Diabetes Investig
; 12(8): 1395-1399, 2021 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-33325645
12.
Glucokinase Inactivation Paradoxically Ameliorates Glucose Intolerance by Increasing ß-Cell Mass in db/db Mice.
Diabetes
; 70(4): 917-931, 2021 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33608422
13.
Glucokinase is required for high-starch diet-induced ß-cell mass expansion in mice.
J Diabetes Investig
; 12(9): 1545-1554, 2021 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-33638884
14.
Lowering of blood pressure and pulse rate by switching from DPP-4 inhibitor to luseogliflozin in patients with type 2 diabetes complicated with hypertension: A multicenter, prospective, randomized, open-label, parallel-group comparison trial (LUNA study).
Diabetes Res Clin Pract
; 180: 109069, 2021 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-34563585
15.
Favorable effect of sodium-glucose cotransporter 2 inhibitor, dapagliflozin, on non-alcoholic fatty liver disease compared with pioglitazone.
J Diabetes Investig
; 12(7): 1272-1277, 2021 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-33131199
16.
Improved time in range and postprandial hyperglycemia with canagliflozin in combination with teneligliptin: Secondary analyses of the CALMER study.
J Diabetes Investig
; 12(8): 1417-1424, 2021 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-33421309
17.
Effects of switching from a dipeptidyl peptidase-4 inhibitor to luseogliflozin on nocturnal blood pressure in patients with type 2 diabetes: protocol for a multicentre, prospective, randomised, open-label, blinded endpoint parallel-group comparison study.
BMJ Open
; 10(2): e034883, 2020 02 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-32034028
18.
Reduction in glucose fluctuations in elderly patients with type 2 diabetes using repaglinide: A randomized controlled trial of repaglinide vs sulfonylurea.
J Diabetes Investig
; 10(2): 367-374, 2019 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-29963781
19.
Effects of dapagliflozin and/or insulin glargine on beta cell mass and hepatic steatosis in db/db mice.
Metabolism
; 98: 27-36, 2019 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-31202833
20.
The role of glucokinase and insulin receptor substrate-2 in the proliferation of pancreatic beta cells induced by short-term high-fat diet feeding in mice.
Metabolism
; 85: 48-58, 2018 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-29544862